10 CFOs in Clinical Research
Among these clinical research CFOs are finance chiefs at global CROs such as Fortrea, TFS HealthScience and ClinChoice, at an early phase CRO and at a regional CRO in Central and Eastern Europe, and Michael Bonello and Jason Knoblauch have each held the CFO title at Clario. Two pair the CFO job with a second title, president at CTI and COO at HungaroTrial, so the group suits CRO owners pricing studies, handling pass-through costs or preparing the books for an acquirer.
Professionals to explore
Aaron Berg
LinkedInExperience: Chief Financial Officer · TOTAL Diversity Clinical Trial Management
Aaron Berg has held the Chief Financial Officer title at TOTAL Diversity Clinical Trial Management, a full-service contract research organization, twice (2017-2022 and since 2024), and was Vice President, Finance there (2014-2017). Aaron has also been Sr. Director, Finance & Corporate Accounting at Meridian Clinical Research since 2022. Corporate accounting for clinical research businesses fits Aaron.
Is this you? Claim your profile and get paid for calls.
Brian Lawrence
LinkedInExperience: Former Chief Financial Officer · CTI Clinical Trial and Consulting Services
Brian Lawrence has held five titles at CTI Clinical Trial and Consulting Services, a full-service contract research organization: Sr. Manager, Taxation and Financial Planning & Analysis (2015-2016), Senior Director, Finance & Taxation (2016-2020), Vice President, Finance (2020-2022), Chief Financial Officer (2022-2026) and Chief Financial Officer and President since April 2026. Tax and FP&A at a CRO, and combining the CFO and president jobs, are the topics for Brian.
Is this you? Claim your profile and get paid for calls.
Christy Shen
LinkedInExperience: Global CFO · ClinChoice
Global CFO at ClinChoice since 2023, Christy Shen was Senior Vice President, Finance (2020-2023) and VP Finance (2019-2020) there; ClinChoice is a global full-service Contract Research Organization (CRO). Christy was Senior Finance Director, Greater China at IQVIA (2015-2019) and China Commercial Finance Director at Diageo (2013-2014). CRO finance in China and across a global CRO is where Christy can help.
Is this you? Claim your profile and get paid for calls.
Craig Poffenbarger
LinkedInExperience: Chief Financial Officer · Charter Research
Charter Research, a growing clinical trial services business, has had Craig Poffenbarger as Chief Financial Officer since 2021, providing leadership and financial management. Craig was Chief Financial Officer at Compass Research LLC (acquired by Bioclinica) from 2013 to 2017 and at Your Location Lubrication (acquired by Get Spiffy, Inc.) (2018-2020), and CFO & Controller at AZZLY, Inc. (2011-2013). Finance at a clinical research company that was later acquired is the question to bring to Craig.
Is this you? Claim your profile and get paid for calls.
Gabor Kucserka
LinkedInExperience: CFO & COO · HungaroTrial CRO
At HungaroTrial CRO, a regional CRO based in Central and Eastern Europe, Gabor Kucserka has been CFO & COO since 2019, and holds the Chief Financial Officer title at HUNGAROTRIAL Zrt. (HUNGAROTRIAL Inc) over the same years. Gabor has also been SAP Development Manager at Hungrana Ltd. since 2018 and worked on Controlling SAP projects at Hungrana Kft. (2018-2019). Combining finance and operations at a CRO, and SAP controlling, fit Gabor.
Is this you? Claim your profile and get paid for calls.
Jason Knoblauch
LinkedInExperience: Chief Financial Officer · Fortrea
Three CFO titles plus commercial finance at PPD make Jason Knoblauch the pick for study pricing and commercial finance questions. Jason has been Chief Financial Officer at Fortrea, a global CRO, since July 2026, after Chief Financial Officer at Clario (2023-2026) and at Curia (2020-2023), and at PPD was SVP - Business & Commercial Finance (2018-2020) and Interim CFO (2017-2018).
Is this you? Claim your profile and get paid for calls.
Jesper Hjort
LinkedInExperience: Executive Vice President & CFO · TFS HealthScience
A global CRO that supports biotechnology and pharmaceutical companies is how Jesper Hjort describes TFS HealthScience, where Jesper has been Executive Vice President & CFO since 2022. Financial reporting, governance, risk management and forecasting, built in global and listed companies, are the strengths Jesper names, a fit for questions on revenue forecasting, governance and risk management at a global CRO serving biotech and pharma sponsors.
Is this you? Claim your profile and get paid for calls.
Joni Glandon
LinkedInExperience: Chief Financial Officer · Dr. Vince Clinical Research
Early phase study finance, and the step from controller to CFO, fit Joni Glandon, Chief Financial Officer since 2022 at Dr. Vince Clinical Research, which provides early phase CRO services, after Controller at Vince & Associates Clinical Research | An Altasciences Company (2013-2022). Joni was Accounting Supervisor at Bushnell (2012-2013) and Senior Accountant at Lockton (2009-2012) and Pioneer Financial Services (2007-2009).
Is this you? Claim your profile and get paid for calls.
Josefin Johansson
LinkedInExperience: Chief Financial Officer · Aurevia Clinical Research Services - CRO (formerly Scandinavian CRO)
Josefin Johansson has been Chief Financial Officer at Aurevia Clinical Research Services - CRO (formerly Scandinavian CRO), a full-service contract research organization, since 2022, after Senior Audit Associate at PwC Sweden (2017-2022). Josefin also worked in Customer Service at Nordea (2014-2017). The move from audit into a CRO CFO seat makes Josefin a fit for questions on audit readiness and financial controls at a Scandinavian CRO.
Is this you? Claim your profile and get paid for calls.
Michael Bonello
LinkedInExperience: Executive Vice President and Chief Financial Officer · Syneos Health
Complete oversight of global accounting and finance operations of NASDAQ listed clinical research organizations comes with Michael Bonello's role as Executive Vice President and Chief Financial Officer at Syneos Health since 2023. Michael held the same Executive Vice President and Chief Financial Officer title at Clario (2021-2023) and PRA Health Sciences (2018-2021), after Senior Vice President, Chief Accounting Officer and Corporate Controller at PRA Health Sciences, Inc (2008-2018). Public-company CRO reporting and controllership questions fit Michael.
Is this you? Claim your profile and get paid for calls.
Choose the right perspective
For listed-company reporting, Michael Bonello and Jason Knoblauch are the picks, with Jesper Hjort and Christy Shen, based in Sweden and China, for finance at global CROs. Brian Lawrence and Gabor Kucserka combine the CFO job with president or COO duties, Joni Glandon covers early phase CRO finance, Craig Poffenbarger finance at a clinical research company that was later acquired, and Josefin Johansson and Aaron Berg audit and corporate accounting.
Questions to take into the conversation
- 01How do you price a study so that pass-through costs such as investigator fees don't erode your margin?
- 02How should revenue be recognized on multi-year trial contracts when enrollment runs behind plan?
- 03What finance reporting does a CRO need in place before an acquirer or public market investor looks closely at it?
About this directory
This is a professional research starting point based on business profile data retrieved on . Titles and companies reflect that source snapshot; roles marked former had ended by then. Check the linked profiles for current details. Inclusion does not imply Instant Expert membership or availability.